These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12561554)

  • 1. [Analytical methods used in pharmacokinetics studies for biotechnology drugs].
    Ju Z; Sun J
    Wei Sheng Yan Jiu; 2002 Apr; 31(2):133-5. PubMed ID: 12561554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical methods for the quantification of therapeutic monoclonal antibodies and their application in clinical pharmacokinetic studies.
    Damen CW; Schellens JH; Beijnen JH
    Hum Antibodies; 2009; 18(3):47-73. PubMed ID: 19729801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 3-(acetylamino)-6-aminoacridine-derivatized oligosaccharides from recombinant monoclonal antibodies by liquid chromatography-mass spectrometry.
    Clarke A; Harmon B; DeFelippis MR
    Anal Biochem; 2009 Jul; 390(2):209-11. PubMed ID: 19379705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance, advantages and limitations of animal models used in the development of monoclonal antibodies for cancer treatment.
    Loisel S; Ohresser M; Pallardy M; Daydé D; Berthou C; Cartron G; Watier H
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):34-42. PubMed ID: 17197192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody.
    Ramjiawan B; Ariano RE; Mantsch HH; Maiti P; Jackson M
    IEEE Trans Med Imaging; 2002 Oct; 21(10):1317-23. PubMed ID: 12585714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotherapies: are they just like any other drugs?
    Paintaud G; Tonelli D; Postaire E;
    Therapie; 2007; 62(3):229-39. PubMed ID: 17803891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug interaction studies of therapeutic proteins or monoclonal antibodies.
    Mahmood I; Green MD
    J Clin Pharmacol; 2007 Dec; 47(12):1540-54. PubMed ID: 17962422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical engineering.
    Carrondo MJ; Aunins JG
    Curr Opin Biotechnol; 2004 Oct; 15(5):441-3. PubMed ID: 15464375
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry and HPLC for carbohydrate analysis.
    Siemiiatkoski J; Lyubarskaya Y
    Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix-assisted laser desorption/ionization mass spectrometry for the evaluation of the C-terminal lysine distribution of a recombinant monoclonal antibody.
    Lazar AC; Kloczewiak MA; Mazsaroff I
    Rapid Commun Mass Spectrom; 2004; 18(3):239-44. PubMed ID: 14755606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody pharmacokinetics and pharmacodynamics.
    Wang W; Wang EQ; Balthasar JP
    Clin Pharmacol Ther; 2008 Nov; 84(5):548-58. PubMed ID: 18784655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationization of monoclonal antibodies: another step towards the "magic bullet"?
    Vaisitti T; Deaglio S; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):105-12. PubMed ID: 16602624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro biochemical engineering to accelerate the design of industrial-scale downstream processes for biopharmaceutical proteins.
    Titchener-Hooker NJ; Dunnill P; Hoare M
    Biotechnol Bioeng; 2008 Jun; 100(3):473-87. PubMed ID: 18438873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotechnology. Hatching the golden egg: a new way to make drugs.
    Alper J
    Science; 2003 May; 300(5620):729-30. PubMed ID: 12730574
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of selected analytical techniques for protein sizing, quantitation and molecular weight determination.
    Goetz H; Kuschel M; Wulff T; Sauber C; Miller C; Fisher S; Woodward C
    J Biochem Biophys Methods; 2004 Sep; 60(3):281-93. PubMed ID: 15345296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
    Sharkey RM; Karacay H; Cardillo TM; Chang CH; McBride WJ; Rossi EA; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7109s-7121s. PubMed ID: 16203810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.